Jnba Financial Advisors Astrazeneca PLC Transaction History
Jnba Financial Advisors
- $970 Million
- Q4 2024
A detailed history of Jnba Financial Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, Jnba Financial Advisors holds 351 shares of AZN stock, worth $25,005. This represents 0.0% of its overall portfolio holdings.
Number of Shares
351
Previous 351
-0.0%
Holding current value
$25,005
Previous $27,000
18.52%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding AZN
# of Institutions
1,335Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.48 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.99 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.65 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.62 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.36 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $221B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...